Alexander Butwick

Alexander Butwick


Bio:   After completing my fellowship at Stanford, I developed a strong clinical research interest in developing preventive strategies for postpartum hemorrhage. I have been principal investigator on clinical studies which have investigated strategies for optimizing anesthetic outcomes for women undergoing cesarean delivery. I have also developed research interests investigating point-of-care devices for assessing the maternal hematologic and hemostatic profiles during the peripartum period.
My overarching goals are to develop strategies to improve how clinicians both prevent and manage women who experience anticipated and unanticipated severe postpartum hemorrhage after delivery. Examples of such approaches include: the use of risk-stratification approaches to identify women 'at-risk' for postpartum hemorrhage, the use of a massive transfusion protocol in obstetrics.

Stanford Hospital

Professional Education

  • M.S., Department of Health Research and Policy, Stanford University, Epidemiology (2011)
  • FRCA, Fellow of the Royal College of Anaesthetists, UK, Anesthesiology (2003)
  • Residency: South Thames West - St George's School of Anaesthesia (2004) UK
  • Medical Education: St George's Hospital Medical School (1997) England
  • Fellowship: Stanford University School of Medicine (2006) CA
  • Board Certification: Anesthesia, The Royal College of Anaesthetists

Honors & Awards

  • Child Health Research Institute Grant (CHRI), Lucile Packard Childrens Hospital (2015)
  • Gerard W. Ostheimer Lecture: 'What's New in Obstetrics -2011?', Annual Meeting of the Society of Obstetric Anesthesia and Perinatology (2012)
  • Gertie Marx Award (1st prize), Society of Obstetric Anesthesia and Perinatology (SOAP) (2006)
  • Mentored Patient-Oriented Research Career Development Award (K23), NICHD, NIH (2013)
  • Outstanding Interdepartmental Faculty Professor, Department of Obstetrics and Gynecology, Stanford University School of Medicine (2011)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.